FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 2230838 · Received August 26, 2011

Report

Report Number
9612164-2011-01025
Event Type
Injury
Date Received
August 26, 2011
Date of Event
August 4, 2011
Report Date
February 25, 2013
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
BR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVAL RESULTS: (STENT THROMBOSIS/ MYOCARDIAL INFARCTION/REVASC).

Description of Event or Problem · 1

DURING INDEX PROCEDURE THE PT HAD ONE ENDEAVOR SPRINT RAPID EXCHANGE (RX) DRUG-ELUTING STENT IMPLANTED TO THE MID CIRCUMFLEX AND ONE ENDEAVOR SPRINT RX DRUG-ELUTING STENT IMPLANTED TO THE PROXIMAL LAD. APPROX FIVE WEEKS POST INDEX PROCEDURE THE PT WAS REHOSPITALIZED. AN ANGIOGRAM WAS PERFORMED AND STENT THROMBOSIS WAS CONFIRMED. THE FOLLOWING DAY RE-PTCA OF TARGET VESSEL WAS PERFORMED DUE TO THE THROMBOSIS (BALLOON AND BARE METAL STENT). THE INVESTIGATOR INDICATED THAT THE REPORTED EVENTS WERE PROBABLY RELATED TO THE STUDY DEVICE. ONE DAY LATER THE PT SUFFERED A MYOCARDIAL INFARCTION (MI). THE REPORTED MI WAS NOT RELATED TO THE TARGET VESSEL. THE INVESTIGATOR INDICATED THAT REPORTED MI WAS UNRELATED TO THE STUDY STENT. (REF MFR # 9612164201101026).

Description of Event or Problem · 1

INVESTIGATOR INDICATED THAT THE REPORTED TVR AND STENT THROMBOSIS ARE DEFINITELY RELATED TO THE STUDY DEVICE.

Description of Event or Problem · 1

IT WAS CONFIRMED THAT A NON MDT STENT WAS IMPLANTED DURING THE PREVIOUSLY REPORTED REVASCULARIZATION OF TARGET VESSEL PERFORMED FIVE WEEKS POST INDEX PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC IRELAND NA 0001427326

Patients

Seq Age Sex Outcome Treatment
1 50 YR Required Intervention LIPID LOWERING DRUGS| ASA| NITRATE| ACE| CLOPIDOGREL